v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
At-the-market Offering Program
February 2025 Offering [Member]
Common Stock
Class A Common Stock
Common Stock
Class A Common Stock
At-the-market Offering Program
Common Stock
Class A Common Stock
February 2025 Offering [Member]
Common Stock
Class B Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
At-the-market Offering Program
Additional Paid-in Capital
February 2025 Offering [Member]
Accumulated Deficit
Balance at Dec. 31, 2024 $ 49,040     $ 5     $ 2 $ 343,475     $ (294,442)
Balance (in shares) at Dec. 31, 2024       58,076,261     15,055,288        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (9,418)                   (9,418)
Issuance of restricted stock, net (in shares)       29,135              
Issuance of Class A common stock upon exercise of stock options 33             33      
Issuance of Class A common stock upon exercise of stock options (in shares)       41,390              
Issuance of common stock   $ 129             $ 129    
Issuance of common stock (in shares)         126,398            
Issuance of common stock and warrants, net of offering costs     $ 2,385     $ 1       $ 2,384  
Issuance of common stock and warrants, net of offering costs (in shares)           4,511,278          
Issuance of common stock in connection with warrant exercise (in shares)       100              
Stock-based compensation expense 945             945      
Balance at Mar. 31, 2025 43,114     $ 6     $ 2 346,966     (303,860)
Balance (in shares) at Mar. 31, 2025       62,784,562     15,055,288        
Balance at Dec. 31, 2025 41,005     $ 8     $ 2 371,011     (330,016)
Balance (in shares) at Dec. 31, 2025       82,166,458     15,055,288        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (8,623)                   (8,623)
Issuance of restricted stock, net 0                    
Issuance of restricted stock, net (in shares)       575,651              
Issuance of Class A common stock upon exercise of stock options 34             34      
Issuance of Class A common stock upon exercise of stock options (in shares)       44,788              
Issuance of common stock   $ 803             $ 803    
Issuance of common stock (in shares)         678,012            
Issuance of common stock and warrants, net of offering costs 495             495      
Stock-based compensation expense 647             647      
Balance at Mar. 31, 2026 $ 34,361     $ 8     $ 2 $ 372,990     $ (338,639)
Balance (in shares) at Mar. 31, 2026       83,464,909     15,055,288